16-68737420-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000261769.10(CDH1):c.5G>A(p.Gly2Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2S) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CDH1
ENST00000261769.10 missense
ENST00000261769.10 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 1.96
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH1 | NM_004360.5 | c.5G>A | p.Gly2Asp | missense_variant | 1/16 | ENST00000261769.10 | NP_004351.1 | |
CDH1 | NM_001317184.2 | c.5G>A | p.Gly2Asp | missense_variant | 1/15 | NP_001304113.1 | ||
CDH1 | NM_001317185.2 | c.-1611G>A | 5_prime_UTR_variant | 1/16 | NP_001304114.1 | |||
CDH1 | NM_001317186.2 | c.-1815G>A | 5_prime_UTR_variant | 1/15 | NP_001304115.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH1 | ENST00000261769.10 | c.5G>A | p.Gly2Asp | missense_variant | 1/16 | 1 | NM_004360.5 | ENSP00000261769 | P1 | |
CDH1 | ENST00000422392.6 | c.5G>A | p.Gly2Asp | missense_variant | 1/15 | 1 | ENSP00000414946 | |||
CDH1 | ENST00000566612.5 | c.5G>A | p.Gly2Asp | missense_variant, NMD_transcript_variant | 1/15 | 1 | ENSP00000454782 | |||
CDH1 | ENST00000566510.5 | c.5G>A | p.Gly2Asp | missense_variant, NMD_transcript_variant | 1/15 | 5 | ENSP00000458139 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1381472Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 681970
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1381472
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
681970
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Apr 05, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;.;M
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.;.;D
REVEL
Benign
Sift
Uncertain
D;.;.;.;D
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
P;.;.;.;.
Vest4
MutPred
Loss of catalytic residue at G2 (P = 0.0258);Loss of catalytic residue at G2 (P = 0.0258);Loss of catalytic residue at G2 (P = 0.0258);Loss of catalytic residue at G2 (P = 0.0258);Loss of catalytic residue at G2 (P = 0.0258);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at